Cervical cancer cell–derived angiopoietins promote tumor progression
P Yang, N Chen, D Yang, J Crane, B Huang… - Tumor …, 2017 - journals.sagepub.com
Metastatic or recurrent cervical cancer has limited treatment options and a high rate of
mortality. Although anti-vascular endothelial growth factor drugs have shown great promise …
mortality. Although anti-vascular endothelial growth factor drugs have shown great promise …
Cervical cancer cell-derived angiopoietins promote tumor progression.
P Yang, N Chen, D Yang, J Crane, B Huang… - Tumour Biology: the …, 2017 - europepmc.org
Metastatic or recurrent cervical cancer has limited treatment options and a high rate of
mortality. Although anti-vascular endothelial growth factor drugs have shown great promise …
mortality. Although anti-vascular endothelial growth factor drugs have shown great promise …
Cervical cancer cell–derived angiopoietins promote tumor progression
P Yang, N Chen, D Yang, J Crane, B Huang… - Tumor …, 2017 - search.proquest.com
Metastatic or recurrent cervical cancer has limited treatment options and a high rate of
mortality. Although anti-vascular endothelial growth factor drugs have shown great promise …
mortality. Although anti-vascular endothelial growth factor drugs have shown great promise …
Cervical cancer cell-derived angiopoietins promote tumor progression
P Yang, N Chen, D Yang, J Crane… - … biology: the journal …, 2017 - pubmed.ncbi.nlm.nih.gov
Metastatic or recurrent cervical cancer has limited treatment options and a high rate of
mortality. Although anti-vascular endothelial growth factor drugs have shown great promise …
mortality. Although anti-vascular endothelial growth factor drugs have shown great promise …
Cervical cancer cell-derived angiopoietins promote tumor progression
P Yang, N Chen, D Yang, J Crane, B Huang… - Tumor …, 2017 - pure.johnshopkins.edu
Metastatic or recurrent cervical cancer has limited treatment options and a high rate of
mortality. Although anti-vascular endothelial growth factor drugs have shown great promise …
mortality. Although anti-vascular endothelial growth factor drugs have shown great promise …